×
ADVERTISEMENT

JULY 9, 2024

Use of Dalbavancin in Optimizing the Management of ABSSSIs in Patients With Obesity or Diabetes

Use of Dalbavancin in Optimizing The Management of ABSSSIs In Patients With Obesity or Diabetes Faculty Frank LoVecchio, DO, MPH, FACEP Medical Director of Clinical Research College of Health Solutions Arizona State University Emergency Medicine, Medical Toxicology, Addiction Medicine Valleywise Health Medical Center Professor of Emergency Medicine University of Arizona Creighton Medical School Phoenix, Arizona Justin Schmetterer, PharmD, PhC, BCIDP Infectious Disease Pharmacist PGY-2